ESPN is running it back. The Worldwide Leader is bringing Skip Bayless back to do battle with his longtime co-host Stephen A. Smith on “First Take” in a one-time reunion on Friday. The legendary ...

For the first time in nearly a decade, Skip Bayless and Stephen A. Smith will debate each other on ESPN’s "First Take" this Friday. On Monday, the network announced Bayless will join Smith for a ...

The XREAL 1S, Viture Beast and XREAL One Pro represent three distinct approaches to AR/XR glasses, each with its own strengths and compromises. As Kola explains, critical factors such as field of view ...

The arguments setting out the pros and cons of remote working remain divided. On the critical side, a study finds that “flextime fiction” is on the rise. This is apparently with employees using time ...

The Birmingham Stallions won three consecutive spring football championships before falling short of their goals during the 2025 UFL season. The Stallions will try to return to the top during the 2026 ...

Americans are driving less, skipping meals and putting off big life moves, like buying homes or having children, to keep up with health care costs, according to two Gallup polls released Thursday.

Dieticians are warning that GLP-1 use can lead to extreme malnutrition, manifesting in diseases like scurvy, amid findings that the vast majority of studies fail to consider patients’ eating habits.

GLP-1 drugs — including Ozempic and Wegovy — may be tied to a slightly higher risk of osteoporosis and gout, according to research presented Monday at the American Academy of Orthopaedic Surgeons’ ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. You might not be destined for a cubicle after all. As a number of big-name companies increase their ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. But ...

Glucagon-like peptide-1 (GLP-1) receptor agonists have revolutionized the treatment of type 2 diabetes and obesity. However, for many users, the benefits of weight loss and blood sugar management come ...